{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:42:57Z","timestamp":1761417777804},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T00:00:00Z","timestamp":1309392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T00:00:00Z","timestamp":1309392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/gt.2011.94","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T10:40:53Z","timestamp":1309430453000},"page":"355-364","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Encapsulated engineered myoblasts can cure Hurler syndrome: preclinical experiments in the mouse model"],"prefix":"10.1038","volume":"19","author":[{"given":"E","family":"Piller Puicher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Tomanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Salvalaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Friso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Hortelano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Marin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,30]]},"reference":[{"key":"BFgt201194_CR1","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J . The mucopolysaccharidoses. In: The Metabolic and Molecular Bases of Inherited Disease, Vol. 3. McGraw-Hill Professional Publishing: New York, 2001, pp 3421\u20133452."},{"key":"BFgt201194_CR2","doi-asserted-by":"crossref","unstructured":"Illsinger S, Lucke T, Hartmann H, Mengel E, Muller-Forell W, Donnerstag F et al. Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression. J Inherit Metab Dis. Short Report #190 (2009), Published online 4 November 2009; doi:10.1007\/s10545-009-1265-y.","DOI":"10.1007\/s10545-009-1265-y"},{"key":"BFgt201194_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","volume":"2","author":"JR Hobbs","year":"1981","unstructured":"Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709\u2013712.","journal-title":"Lancet"},{"key":"BFgt201194_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bmt.1703839","volume":"31","author":"C Peters","year":"2003","unstructured":"Peters C, Steward CG . Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 2003; 31: 229\u2013239.","journal-title":"Bone Marrow Transplant"},{"key":"BFgt201194_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1023\/A:1010379320378","volume":"24","author":"JE Wraith","year":"2001","unstructured":"Wraith JE . Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. J Inherit Metab Dis 2001; 24: 245\u2013250.","journal-title":"J Inherit Metab Dis"},{"key":"BFgt201194_CR6","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1542\/peds.2006-2156","volume":"120","author":"JE Wraith","year":"2007","unstructured":"Wraith JE, Beck M, Lane R, van der Ploeg A, Shapiro E, Xue Y et al. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase). Pediatrics 2007; 120: e37\u2013e46.","journal-title":"Pediatrics"},{"key":"BFgt201194_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/sj.bmt.1705988","volume":"41","author":"C Messina","year":"2008","unstructured":"Messina C, Rampazzo A, Cesaro S, Monciotti C, Gasparotto N, Tomanin R et al. Eighteen-year follow-up of the first Italian MPSI patient treated with bone marrow transplantation. Bone Marrow Transplant 2008; 41: 905\u2013906.","journal-title":"Bone Marrow Transplant"},{"key":"BFgt201194_CR8","volume-title":"GeneReviews","author":"LA Clarke","year":"1993","unstructured":"Clarke LA . Mucopolysaccharidosis Type I. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds). GeneReviews. University of Washington, Seattle: Seattle (WA), 1993."},{"key":"BFgt201194_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.bbamcr.2008.08.009","volume":"1793","author":"FM Platt","year":"2009","unstructured":"Platt FM, Lachmann RH . Treating lysosomal storage disorders: current practice and future prospects. Biochim Biophys Acta 2009; 1793: 737\u2013745.","journal-title":"Biochim Biophys Acta"},{"key":"BFgt201194_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1749-6632.1997.tb52218.x","volume":"831","author":"PL Chang","year":"1997","unstructured":"Chang PL . Microcapsules as bio-organs for somatic gene therapy. Ann NY Acad Sci 1997; 831: 461\u2013473.","journal-title":"Ann NY Acad Sci"},{"key":"BFgt201194_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1089\/104303400750001426","volume":"11","author":"CJ Ross","year":"2000","unstructured":"Ross CJ, Bastedo L, Maier SA, Sands MS, Chang PL . Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells. Hum Gene Ther 2000; 11: 2117\u20132127.","journal-title":"Hum Gene Ther"},{"key":"BFgt201194_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.addr.2010.02.004","volume":"62","author":"RM Hernandez","year":"2010","unstructured":"Hernandez RM, Orive G, Murua A, Pedraz JL . Microcapsules and microcarriers for in situ cell delivery. Adv Drug Deliv Rev 2010; 62: 711\u2013730.","journal-title":"Adv Drug Deliv Rev"},{"key":"BFgt201194_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.lab.2003.07.002","volume":"142","author":"SC Barsoum","year":"2003","unstructured":"Barsoum SC, Milgram W, Mackay W, Coblentz C, Delaney KH, Kwiecien JM et al. Delivery of recombinant gene product to canine brain with the use of microencapsulation. J Lab Clin Med 2003; 142: 399\u2013413.","journal-title":"J Lab Clin Med"},{"key":"BFgt201194_CR14","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/jgm.790","volume":"7","author":"A Friso","year":"2005","unstructured":"Friso A, Tomanin R, Alba S, Gasparotto N, Puicher EP, Fusco M et al. Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts. J Gene Med 2005; 7: 1482\u20131491.","journal-title":"J Gene Med"},{"key":"BFgt201194_CR15","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1073\/pnas.252784899","volume":"100","author":"K Ohmi","year":"2003","unstructured":"Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF . Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 2003; 100: 1902\u20131907.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201194_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/jgm.852","volume":"8","author":"J Wen","year":"2006","unstructured":"Wen J, Vargas AG, Ofosu FA, Hortelano G . Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells. J Gene Med 2006; 8: 362\u2013369.","journal-title":"J Gene Med"},{"key":"BFgt201194_CR17","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1056\/NEJMp048084","volume":"350","author":"J Muenzer","year":"2004","unstructured":"Muenzer J, Fisher A . Advances in the treatment of mucopolysaccharidosis type I. N Engl J Med 2004; 350: 1932\u20131934.","journal-title":"N Engl J Med"},{"key":"BFgt201194_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","volume":"27","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ . Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 2004; 27: 385\u2013410.","journal-title":"J Inherit Metab Dis"},{"key":"BFgt201194_CR19","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/jgm.1229","volume":"10","author":"RS Herati","year":"2008","unstructured":"Herati RS, Ma X, Tittiger M, Ohlemiller KK, Kovacs A, Ponder KP . Improved retroviral vector design results in sustained expression after adult gene therapy in mucopolysaccharidosis I mice. J Gene Med 2008; 10: 972\u2013982.","journal-title":"J Gene Med"},{"key":"BFgt201194_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12519-009-0062-x","volume":"5","author":"S Mercimek-Mahmutoglu","year":"2009","unstructured":"Mercimek-Mahmutoglu S, Reilly C, Human D, Waters PJ, Stoeckler-Ipsiroglu S . Progression of organ manifestations upon enzyme replacement therapy in a patient with mucopolysaccharidosis type I\/Hurler. World J Pediatr 2009; 5: 319\u2013321.","journal-title":"World J Pediatr"},{"key":"BFgt201194_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/mgme.2000.3140","volume":"72","author":"ED Kakkis","year":"2001","unstructured":"Kakkis ED, Schuchman E, He X, Wan Q, Kania S, Wiemelt S et al. Enzyme replacement therapy in feline mucopolysaccharidosis I. Mol Genet Metab 2001; 72: 199\u2013208.","journal-title":"Mol Genet Metab"},{"key":"BFgt201194_CR22","unstructured":"Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004 (Text with EEA relevance). OJ 2007; L324: 121\u2013137."},{"key":"BFgt201194_CR23","first-page":"53248","volume":"58","author":"Food and Drug Administration","year":"1993","unstructured":"Food and Drug Administration. Application of current statutory authorities to human somatic cell therapy products and gene therapy products. Fed Regist 1993; 58: 53248\u201353251.","journal-title":"Fed Regist"},{"key":"BFgt201194_CR24","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.biomaterials.2009.01.014","volume":"30","author":"P de Vos","year":"2009","unstructured":"de Vos P, Bucko M, Gemeiner P, Navratil M, Svitel J, Faas M et al. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009; 30: 2559\u20132570.","journal-title":"Biomaterials"},{"key":"BFgt201194_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/dna.1993.12.777","volume":"12","author":"DL Montgomery","year":"1993","unstructured":"Montgomery DL, Shiver JW, Leander KR, Perry HC, Friedman A, Martinez D et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol 1993; 12: 777\u2013783.","journal-title":"DNA Cell Biol"},{"key":"BFgt201194_CR26","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1182\/blood.V87.12.5095.bloodjournal87125095","volume":"87","author":"G Hortelano","year":"1996","unstructured":"Hortelano G, Al-Hendy A, Ofosu FA, Chang PL . Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood 1996; 87: 5095\u20135103.","journal-title":"Blood"},{"key":"BFgt201194_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/hum.2005.16.81","volume":"16","author":"C Di Domenico","year":"2005","unstructured":"Di Domenico C, Villani GR, Di Napoli D, Reyero EG, Lombardo A, Naldini L et al. Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector. Hum Gene Ther 2005; 16: 81\u201390.","journal-title":"Hum Gene Ther"},{"key":"BFgt201194_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1651-2227.2002.tb03119.x","volume":"91","author":"R Tomanin","year":"2002","unstructured":"Tomanin R, Friso A, Alba S, Piller Puicher E, Mennuni C, La Monica N et al. Non-viral transfer approaches for the gene therapy of mucopolysaccharidosis type II (Hunter syndrome). Acta Paediatr Suppl 2002; 91: 100\u2013104.","journal-title":"Acta Paediatr Suppl"},{"key":"BFgt201194_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/abio.1993.1197","volume":"210","author":"S Bjornsson","year":"1993","unstructured":"Bjornsson S . Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue. Anal Biochem 1993; 210: 282\u2013291.","journal-title":"Anal Biochem"},{"key":"BFgt201194_CR30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/35.3.374","volume":"35","author":"CB Whitley","year":"1989","unstructured":"Whitley CB, Ridnour MD, Draper KA, Dutton CM, Neglia JP . Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion. Clin Chem 1989; 35: 374\u2013379.","journal-title":"Clin Chem"},{"key":"BFgt201194_CR31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/38.6.803","volume":"38","author":"JG de Jong","year":"1992","unstructured":"de Jong JG, Wevers RA, Liebrand-van Sambeek R . Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 1992; 38: 803\u2013807.","journal-title":"Clin Chem"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201194","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:11:08Z","timestamp":1648552268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,30]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFgt201194"],"URL":"https:\/\/doi.org\/10.1038\/gt.2011.94","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,30]]},"assertion":[{"value":"31 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}